TUESDAY, Oct. 1, 2019 (HealthDay News) — A tuberculosis vaccine commonly used in other parts of the world might reduce a person’s risk of developing lung cancer if given early in childhood, a six-decade-long study reports. The Bacille Calmette-Guerin (BCG) vaccine is the only vaccine approved for preventing tuberculosis (TB)Continue Reading
TUESDAY, Oct. 1, 2019 (HealthDay News) — One in three people with lupus uses opioid painkillers even though there is little evidence that they reduce the pain of rheumatic diseases, a new study finds. “Rheumatic diseases, such as lupus, are a leading cause of chronic pain,” said lead author EmilyContinue Reading
(HealthDay News) — Influenza, commonly known as the flu, is a potentially serious disease that can lead to hospitalization and death, says the U.S. Centers for Disease Control and Prevention. An annual seasonal flu shot is the best way to protect against the disease. The CDC offers these facts onContinue Reading
FRIDAY, Sept. 27, 2019 (HealthDay News) — In the largest investigation of its kind, researchers conclude that subjecting prostate cancer patients to radiation therapy immediately after surgery doesn’t give them an advantage in staying cancer-free. The finding stems from a review of four studies that together tracked outcomes for moreContinue Reading
THURSDAY, Sept. 26, 2019 (HealthDay News) — A constant barrage of news on America’s opioid epidemic stokes feelings of hopelessness, and with good reason: Every day, more than 130 people are dying from overdoses, according to government statistics. But amid the harrowing stories, there’s some good news: It is possibleContinue Reading
Jynneos is approved for adults considered at high risk for infectionContinue Reading
MONDAY, Sept. 23, 2019 (HealthDay News) — Many people who take the antidepressant Zoloft report feeling better. But new research suggests the drug may be treating their anxiety, rather than their depression, at least in the early weeks. Zoloft (sertraline) — and the family of similar drugs it belongs toContinue Reading
MONDAY, Sept. 23, 2019 (HealthDay News) — Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest. The first reviewed data on 460 patients with head and neck squamous cell carcinoma (HNSCC) or early stage non-small cell lung cancer (NSCLC). That study concludedContinue Reading
THURSDAY, Sept. 19, 2019 (HealthDay News) — Novartis, the maker of a generic form of the popular heartburn drug Zantac, said Wednesday it will cease distribution of the medicine after investigations suggested that generic and branded versions contain a known carcinogen. A distribution halt is not the same as aContinue Reading
MONDAY, Sept. 16, 2019 (HealthDay News) — When a child gets sick, doctors are increasingly relying on what’s known as “off-label” use of medications, a new study says. Off-label use of a drug means that it hasn’t been specifically studied and approved for the condition, age group or weight ofContinue Reading